| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 2.270.020.188 $ | 99,99 | 37.752.668 | |||||||
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 119.445.481 $ | 5,26 | 2.351.289 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 98.938.120 $ | 4,36 | 166.849 | |
| Alkermes PLC | Alkermes PLC SHS | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 96.146.103 $ | 4,24 | 2.719.064 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 92.819.305 $ | 4,09 | 665.992 | |
| Axsome Therapeutics Inc. | Axsome Therapeutics Inc. COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 88.207.820 $ | 3,89 | 521.878 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 87.006.524 $ | 3,83 | 247.283 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics Inc. COM | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 86.691.734 $ | 3,82 | 2.150.626 | |
| Krystal Biotech Inc | Krystal Biotech Inc COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 79.692.753 $ | 3,51 | 308.504 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 78.804.950 $ | 3,47 | 429.853 | |
| Exelixis, Inc. | Exelixis, Inc. COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 78.543.170 $ | 3,46 | 1.831.270 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 78.243.811 $ | 3,45 | 593.926 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 78.229.027 $ | 3,45 | 101.249 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 77.623.834 $ | 3,42 | 173.834 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 77.280.580 $ | 3,40 | 1.368.040 | |
| Argenx SE | Argenx SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 74.722.831 $ | 3,29 | 102.325 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 73.643.325 $ | 3,24 | 3.384.344 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 71.923.043 $ | 3,17 | 1.112.843 | |
| BioNTech SE | BioNTech SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 71.789.354 $ | 3,16 | 807.711 | |
| Incyte Corporation. | Incyte Corporation. COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 71.025.870 $ | 3,13 | 754.631 | |
| BEONE MEDICINES LTD | BeOne Medicines Ltd. SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 70.878.424 $ | 3,12 | 238.672 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 70.471.563 $ | 3,10 | 571.731 | |
| NATERA INC | Natera Inc. COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 68.836.158 $ | 3,03 | 344.198 | |
| Acadia Pharmaceuticals Inc | Acadia Pharmaceuticals Inc COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 67.035.879 $ | 2,95 | 3.011.495 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 66.998.528 $ | 2,95 | 202.492 | |
| Bio-Techne Corp | Bio-Techne Corp COM | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 64.153.070 $ | 2,83 | 1.227.575 | |
| Genmab As | Genmab As SPONSORED ADS | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 63.158.330 $ | 2,78 | 2.354.019 | |
| Veracyte Inc | Veracyte Inc COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 61.789.764 $ | 2,72 | 1.918.341 | |
| Repligen Corporation | Repligen Corporation COM | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 56.958.076 $ | 2,51 | 483.433 | |
| Bruker Corporation | Bruker Corporation COM | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 53.490.939 $ | 2,36 | 1.480.923 | |
| Neogenomics Inc | Neogenomics Inc COM NEW | EC | 64049M209 | Long | Börsenkurs (Stufe 1) | 45.471.823 $ | 2,00 | 6.128.278 | |
| 2.270.020.188 $ | 99,99 | 37.752.668 |